All results

1 results for phase iii multicentre international randomised parallel group double blind

• Octapharma LEX-210

  This is a multicentre, prospective, randomised, double-blinded, group-sequential, parallel-group, adaptive design, phase 3 study to demonstrate the haemostatic…

  Ages

  18 Years - N/A

  Sexes

  All